Investment firm Goldman Sachs has downgraded its rating for Danish pharmaceutical company Novo Nordisk from “buy” to “neutral” following disappointing results from a recent phase 3...
The performance of the Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) and the Global X NASDAQ 100 Covered Call ETF (QYLD) has drawn significant attention as...
URGENT UPDATE: Hedge funds have swiftly exited technology stocks in Japan and Hong Kong, according to a recent Goldman Sachs note, as market concerns over inflated...
UPDATE: Despite widespread concerns about a potential market bubble, global asset managers are doubling down on stocks, revealing a strong “risk-on” sentiment. This follows a remarkable...
Goldman Sachs has unveiled its updated list of the top 20 S&P 500 stocks favored by hedge fund managers, highlighting a significant shift in investment strategies....
Wall Street braces for a week of heightened volatility as the U.S.-China trade tensions escalate and the government shutdown continues. Major financial institutions, including JPMorgan Chase,...
Investors are increasingly eyeing Goldman Sachs BDC (GSBD), which currently trades at a significant 24.6% discount to its net asset value (NAV). This marks one of...
The Goldman Sachs GQG Partners International Opportunities Fund experienced a significant underperformance during the second quarter of 2025, lagging behind the MSCI ACWI ex-USA (Net) benchmark...
UPDATE: Goldman Sachs Co-Head in Paris, Celine-Marie Mechain, has just announced that merger and acquisition (M&A) activity in France is set to accelerate despite ongoing political...
UPDATE: Goldman Sachs’ chief global equity strategist, Peter Oppenheimer, issues a stark warning as US stock prices surge, urging investors to reconsider their strategies. Recent market...
